aminocaproic acid has been researched along with Eye Hemorrhage in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Eye Hemorrhage: Intraocular hemorrhage from the vessels of various tissues of the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report the characteristics and functional outcome of patients with traumatic hyphema and to discuss possible recommendations regarding the use of epsilon-aminocaproic acid." | 7.71 | Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid. ( Beiran, I; Miller, B; Talmon, T, 2002) |
| "To report the characteristics and functional outcome of patients with traumatic hyphema and to discuss possible recommendations regarding the use of epsilon-aminocaproic acid." | 3.71 | Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid. ( Beiran, I; Miller, B; Talmon, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beiran, I | 1 |
| Talmon, T | 1 |
| Miller, B | 1 |
| Javitt, JC | 1 |
2 other studies available for aminocaproic acid and Eye Hemorrhage
| Article | Year |
|---|---|
Characteristics and functional outcome of traumatic hyphema without routine administration of epsilon-aminocaproic acid.
Topics: Adolescent; Adult; Aminocaproic Acid; Antifibrinolytic Agents; Child; Eye Hemorrhage; Humans; Hyphem | 2002 |
When does the failure to find a difference mean that there is none?
Topics: Adrenergic beta-Antagonists; Aminocaproic Acid; Blood Gas Monitoring, Transcutaneous; Clinical Trial | 1989 |